Skip Ribbon Commands
Skip to main content
Clin Asst Prof Sheldon Lee Shao Guang

Clin Asst Prof Sheldon Lee Shao Guang

M.B.B.S, MRCP (U.K), M.Med Int Med

Senior Consultant

Changi General Hospital

Specialty: Cardiology

Sub-specialties: Heart Failure, Non-invasive Cardiac Imaging, Cardiac Magnetic Resonance Imaging

Conditions Treated by this Doctor:
Heart Attack (Myocardial Infarction), Heart Failure.

Clinical Appointments

  • Senior Consultant Cardiology Changi General HospitalChangi General Hospital


Dr Sheldon Lee Shao Guang graduated from the National University of Singapore (NUS), Yong Loo Lin School of Medicine in 2003. He then went on to obtain his MRCP(UK) in 2010, and registered as a cardiologist with SMC since 2013. Dr Lee went for a fellowship in advanced heart failure management at St Vincent’s Hospital, New South Wales, Australia from 2015 to 2016 and completed another fellowship in cardiac magnetic resonance imaging in the Royal Brompton Hospital, London, U.K in 2016.

His areas of sub-specialisation and interest are in advanced heart failure management and non-invasive cardiac imaging.


  • MRCP (UK)
  • M.B.B.S

Professional Appointments and Committee Memberships

  • Senior Clinical lecturer - NUS Yong Loo Lin School of Medicine
  • Clinical Assistant Professor - SingHealth Duke-NUS Cardiovascular Sciences Academic Clinical Programme (CVS ACP)
  • Core Faculty - SingHealth Cardiology Senior Residency
  • Director - Heart Failure Program, Changi General Hospital
  • Cardiology Representative - Pharmacy and Therapeutics Committee
  • Physician champion - Cardio-Pharmacist clinic
  • Member - Heart Failure Service Improvements Sub-committee


Research Interests


  • Prognostic Factors After Index Hospitalization for Heart Failure With Preserved Ejection Fraction - Co-Author. Published in the American journal of Cardiology in June 2017
  • Risk Stratification Model for 30-Day Heart Failure Readmission in a Multi-Ethnic South East Asian Community -- Co-Author. The American Journal of Cardiology May 2017

Research Trials

  • A Randomized Parallel-Group, Placebo-Controlled, Double-Blind, Event-Driven, Multi-Center Pivotal Phase III Clinical Outcome Trial of Efficacy and Safety of the Oral sGC Stimulator Vericiguat in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF) - VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) – Site PI
  • Asian Sudden Cardiac Death in Heart Failure (ASIAN-HF) study – Site PI
  • Asian Network for Translational Research and Cardiovascular Trials (ATTRaCT) – Site PI